<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04802629</url>
  </required_header>
  <id_info>
    <org_study_id>HbF Version 1.3</org_study_id>
    <nct_id>NCT04802629</nct_id>
  </id_info>
  <brief_title>Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.</brief_title>
  <acronym>HbFIN</acronym>
  <official_title>Influence of Fetal Haemoglobin on Cerebral and Peripheral Oxygenation in Term and Preterm Neonates During the First Two Weeks After Birth Measured by Near Infrared Spectroscopy- a Prospective Observational Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the relationship between cerebral and peripheral&#xD;
      oxygenation and oxygen extraction, as measured by NIRS (near-infrared spectroscopy ), and the&#xD;
      FHbF (fraction of fetal hemoglobin) and absolute HbF (fetal hemoglobin) concentration in&#xD;
      postnatal conditions in term and preterm neonates.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During gestation the main fetal oxygen carrier is fetal hemoglobin (HbF). HbF exhibits a&#xD;
      significantly higher affinity for oxygen when compared to adult hemoglobin (HbA), which makes&#xD;
      it more suitable for oxygen extraction at the lower partial oxygen pressures in utero.&#xD;
      Although the regulation of HbF expression is determined developmentally, recent studies&#xD;
      report a respectable variation in the fraction of HbF in neonates.&#xD;
&#xD;
      Such data suggest that the differences in HbF expression could affect end-tissue oxygenation&#xD;
      in neonates.&#xD;
&#xD;
      The methodology for measuring oxygen saturation and extraction in cerebral and peripheral&#xD;
      tissues of neonates using the near-infrared spectroscopy (NIRS) has been well practiced in&#xD;
      our study group. However, the method has not yet been used to investigate whether the&#xD;
      fraction of fetal hemoglobin (FHbF) plays a significant role in cerebral and peripheral&#xD;
      oxygenation in neonates.&#xD;
&#xD;
      The aim of this study is to investigate the relationship between cerebral and peripheral&#xD;
      oxygenation and oxygen extraction, as measured by NIRS, and the FHbF and absolute HbF&#xD;
      concentration in postnatal conditions in term and preterm neonates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Weeks</target_duration>
  <primary_outcome>
    <measure>FHbF (%)</measure>
    <time_frame>First two weeks after birth</time_frame>
    <description>Fraction of fetal hemoglobin in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HbF (g/dL)</measure>
    <time_frame>First two weeks after birth</time_frame>
    <description>Fetal hemoglobin concentration in g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of cTOI</measure>
    <time_frame>at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)</time_frame>
    <description>cerebral tissue oxygenation index (cTOI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of pTOI</measure>
    <time_frame>at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)</time_frame>
    <description>peripheral tissue oxygenation index (pTOI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of cFTOE</measure>
    <time_frame>at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)</time_frame>
    <description>cerebral fractional tissue oxygen extraction (cFTOE)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of pFTOE</measure>
    <time_frame>at specific time points (2nd-3rd 6th-8th, 12th-14th day after birth)</time_frame>
    <description>peripheral fractional tissue oxygen extraction (pFTOE)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Preterm Birth</condition>
  <condition>Oxygen Toxicity</condition>
  <condition>Fetal Hemoglobin</condition>
  <arm_group>
    <arm_group_label>Term neonates</arm_group_label>
    <description>≥ 37+0 weeks of gestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm neonates</arm_group_label>
    <description>≤ 36+6 weeks of gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Near-infrared spectroscopy</intervention_name>
    <description>For NIRS measurements the t-NIRS 1 and NIRO 200 NX (Hamamatsu, Japan) will be used. A cerebral sensor will be placed and fixed with a CPAP (Continuous Positive Airway Pressure) cap on the left forehead and a peripheral sensor on the right forearm. Duration of measurement will be two hours.</description>
    <arm_group_label>Preterm neonates</arm_group_label>
    <arm_group_label>Term neonates</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Preterm neonates (≤ 36+6 weeks of gestation) and term neonates (≥ 37+0 weeks of gestation)&#xD;
        admitted to the NICU.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Term and preterm neonates admitted to the neonatal intensive care unit (NICU)&#xD;
&#xD;
          -  Decision to conduct full life support&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No decision to conduct full life support&#xD;
&#xD;
          -  No written informed consent&#xD;
&#xD;
          -  Congenital malformations&#xD;
&#xD;
          -  Family history of haemoglobinopathies (e.g. sickle cell anaemia, thalassaemia)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Pichler, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerhard Pichler, Prof</last_name>
    <phone>+43 316 385 80520</phone>
    <email>gerhard.pichler@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ena Pritisanac, MD</last_name>
    <phone>+43 316 385 80531</phone>
    <email>ena.pritisanac@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pediatrics, Division of Neonatology, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Pichler, MD</last_name>
      <phone>0043 316 385 80520</phone>
      <email>gerhard.pichler@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Ena Pritisanac, MD</last_name>
      <phone>0043 316 385 80531</phone>
      <email>ena.pritisanac@medunigraz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Gerhard Pichler, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ena Pritisanac, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fetal hemoglobin</keyword>
  <keyword>preterm neonate</keyword>
  <keyword>term neonate</keyword>
  <keyword>near-infrared spectroscopy</keyword>
  <keyword>cerebral oxygenation</keyword>
  <keyword>peripheral oxygenation</keyword>
  <keyword>fractional tissue oxygen extraction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

